PPIPT00031
Target Protein Information
| Protein_Name | Histone-binding protein RBBP4 |
|---|---|
| Protein_Sequence | MADKEAAFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLPDVTRPEGKDFSIHRLVLGTHTSDEQNHLVIASVQLPNDDAQFDASHYDSEKGEFGGFGSVSGKIEIEIKINHEGEVNRARYMPQNPCIIATKTPSSDVLVFDYTKHPSKPDPSGECNPDLRLRGHQKEGYGLSWNPNLSGHLLSASDDHTICLWDISAVPKEGKVVDAKTIFTGHTAVVEDVSWHLLHESLFGSVADDQKLMIWDTRSNNTSKPSHSVDAHTAEVNCLSFNPYSEFILATGSADKTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLNVWDLSKIGEEQSPEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQVWQMAENIYNDEDPEGSVDPEGQGS |
| Organism_Source | Homo sapiens |
| Functional_Classification | Histone-binding protein / chromatin remodeling factor |
| Cellular_Localization | Nucleus |
| Gene_Names | RBBP4 |
| UniProt_ID | Q09028 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | FFW (peptide 46) |
|---|---|
| Peptide_Sequence | RRKFAKFQWI |
| Peptide_Length | 10 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Acetyl |
| C-terminal_Modification | Amide |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1379.67 |
|---|---|
| Aliphatic_Index | 49.00000 |
| Aromaticity | 0.30000 |
| Average_Rotatable_Bonds | 4.60000 |
| Charge_at_pH_7 | 3.99739 |
| Isoelectric_point | 12.53175 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 16 |
| Number_of_Hydrogen_Bond_Donors | 21 |
| Topological_Polar_Surface_Area | 559.94000 |
| X_logP_energy | -1.91306 |
Interaction Information
| Affinity | IC50=0.023 uM |
|---|---|
| Affinity_Assay | Fluorescence Polarization |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | THERAPEUTIC SALL4 PEPTIDE |
| Release_Year | 2019 |
| Patent_ID | US20190218253A1 |